NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
-1.83%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.21B
AUM Growth
-$221M
(-15%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
42.91%
Holding
147
New
18
Increased
38
Reduced
57
Closed
11
Top Buys
| 1 |
RH
RH
|
+$11.8M |
| 2 |
Hilton Grand Vacations
HGV
|
+$9.57M |
| 3 |
Gogo Inc
GOGO
|
+$8.54M |
| 4 |
THRD
Third Harmonic Bio
THRD
|
+$8.46M |
| 5 |
Avalo Therapeutics
AVTX
|
+$7.21M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$155M |
| 2 |
Peloton Interactive
PTON
|
+$18.1M |
| 3 |
BlackSky Technology
BKSY
|
+$14.9M |
| 4 |
Pathward Financial
CASH
|
+$14.1M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$13.7M |
Sector Composition
| 1 | Healthcare | 63.52% |
| 2 | Consumer Discretionary | 15.44% |
| 3 | Communication Services | 7.06% |
| 4 | Financials | 4.59% |
| 5 | Industrials | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
The RMR Group
RMR
$288M
| $12.3M | 0.49% |
736,202
+285,410
| +63% | +$4.75M |
|
|
27
RH
RH
$4.08B
| $11.8M | 0.47% |
+50,158
| New | +$11.8M |
|
28
Zevra Therapeutics
ZVRA
$435M
| $11M | 0.44% |
1,471,936
-868,397
| -37% | -$6.5M |
|
29
Reservoir Media
RSVR
$517M
| $11M | 0.44% |
1,442,136
-118,661
| -8% | -$905K |
|
30
Benitec Biopharma
BNTC
$364M
| $10.9M | 0.43% |
838,095
| – | – |
|
31
Amylyx Pharmaceuticals
AMLX
$1.04B
| $10.4M | 0.41% |
2,934,405
+1,482,252
| +102% | +$5.25M |
|
|
THRD
32
DELISTED
Third Harmonic Bio
THRD
| $10.2M | 0.41% |
2,938,700
+2,437,700
| +487% | +$8.46M |
|
|
ABVX
33
Abivax
ABVX
$6.35B
| $9.27M | 0.37% |
1,482,994
+46,947
| +3% | +$293K |
|
|
RDNW
34
RideNow Group, Inc. Class B Common Stock
RDNW
$156M
| $9.23M | 0.37% |
3,272,845
-1,293
| -0% | -$3.65K |
|
|
OPTN
35
DELISTED
OptiNose
OPTN
| $9.04M | 0.36% |
985,333
-698
| -0.1% | -$6.4K |
|
36
eHealth
EHTH
$122M
| $8.76M | 0.35% |
1,311,441
-698,059
| -35% | -$4.66M |
|
|
ILPT
37
Industrial Logistics Properties Trust
ILPT
$424M
| $8.62M | 0.34% |
2,506,244
+398,351
| +19% | +$1.37M |
|
38
Tourmaline Bio
TRML
$1.22B
| $8.1M | 0.32% |
532,824
-4,120
| -0.8% | -$62.7K |
|
|
CMPS
39
Compass Pathways
CMPS
$499M
| $8.09M | 0.32% |
2,829,232
+1,829,232
| +183% | +$5.23M |
|
40
Elutia
ELUT
$54.3M
| $8.06M | 0.32% |
3,184,947
+320,000
| +11% | +$810K |
|
|
CNTA
41
Centessa Pharmaceuticals
CNTA
$2.92B
| $7.98M | 0.32% |
554,803
+42,156
| +8% | +$606K |
|
42
Codexis
CDXS
$219M
| $7.61M | 0.3% |
2,830,619
-11,041
| -0.4% | -$29.7K |
|
43
Aura Biosciences
AURA
$384M
| $7.43M | 0.3% |
1,267,697
-2,338
| -0.2% | -$13.7K |
|
44
Disc Medicine
IRON
$2.08B
| $7.37M | 0.29% |
148,391
-1,609
| -1% | -$79.9K |
|
|
45
Avalo Therapeutics
AVTX
$140M
| $7.21M | 0.29% |
+900,000
| New | +$7.21M |
|
|
PVLA
46
Palvella Therapeutics, Inc. Common Stock
PVLA
$629M
| $7M | 0.28% |
250,062
| – | – |
|
47
Syndax Pharmaceuticals
SNDX
$1.34B
| $6.81M | 0.27% |
554,503
-6,029
| -1% | -$74.1K |
|
48
Viemed Healthcare
VMD
$263M
| $6.79M | 0.27% |
932,445
-2,677
| -0.3% | -$19.5K |
|
49
The ONE Group
STKS
$81.1M
| $6.34M | 0.25% |
2,121,084
+33,690
| +2% | +$101K |
|
50
InspireMD
NSPR
$99.3M
| $6.24M | 0.25% |
2,318,017
+643,452
| +38% | +$1.73M |
|